Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Janumet 50mg/500mg

Generic: Sitagliptin/Metforminby MSD Pharmaceuticals Pvt. Ltd.

Buy Janumet 50mg/500mg (Sitagliptin/Metformin) online | SafeRxPills

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Januvia 100mg (Sitagliptin) online | SafeRxPills

Januvia 100mg

$73.50View
Buy Amaryl 1mg (Glimepiride) online | SafeRxPills

Amaryl 1mg

$31.00View
Buy Amaryl 2mg (Glimepiride) online | SafeRxPills

Amaryl 2mg

$37.00View
Buy Amaryl 3mg (Glimepiride) online | SafeRxPills

Amaryl 3mg

$60.00View

About Janumet 50mg/500mg

Janumet 50mg/500mg is MSD's tablet for type 2 diabetes that combines two medicines in one film-coated tablet: sitagliptin 50 mg (a DPP-4 inhibitor, the medicine in Januvia) and metformin hydrochloride 500 mg (immediate release). The pack we sell is the Indian Janumet from MSD Pharmaceuticals Pvt Ltd; the carton in our product photo reads "2 Strips of 15 tablets each". Our packs are 30, 60 and 90 tablets. The labels give it twice a day with meals, so at two tablets a day a 30 pack lasts 15 days, a 60 pack 30 days and a 90 pack 45 days, at about $1.89 to $2.20 a day before shipping (our arithmetic; see Price per tablet and per day).

Three points before you read further. First, this is the lower Janumet strength: the US label names 50 mg/500 mg twice daily as the starting dose for people not already taking metformin, with gradual dose escalation to reduce stomach side effects, so your dose may change after the first weeks. Second, two tablets a day already give the maximum daily sitagliptin dose of 100 mg, so never take more than two tablets in a day, even though the metformin in them (1000 mg a day) is half the labelled maximum; a higher metformin dose needs a different strength, not more of these tablets. Third, it needs a doctor: kidney tests (eGFR) before you start and at least once a year, and blood glucose and HbA1c checks. Janumet carries a boxed warning for lactic acidosis. In the US, generic sitagliptin and metformin 50 mg/500 mg tablets from Sandoz and Apotex list a marketing start date of 28 May 2026 in the FDA's NDC directory, so US readers should compare those first. This page uses the current US Janumet label, the UK Janumet product information and Indian pharmacy listings, all listed at the end.

Janumet 50mg/500mg at a glance

Active ingredientsSitagliptin 50 mg (as sitagliptin phosphate) and metformin hydrochloride 500 mg in one film-coated tablet (Truemeds, PharmEasy and Medkart listings; the carton in our product photo)
Brand and makerJanumet, MSD Pharmaceuticals Pvt Ltd (India), per the Truemeds and Medkart listings, with the MSD logo on the carton in our product photo; PharmEasy's listing names Abbott Healthcare under "Made by", so read the maker line on the strip you receive
Drug classesDPP-4 inhibitor (sitagliptin) and biguanide (metformin)
Regulatory statusJanumet 50 mg/500 mg is licensed in the US (FDA), Canada and Australia, with generic versions sold in all three. In the UK, sitagliptin with metformin is licensed, but on the UK emc we found it only at 50 mg/850 mg and 50 mg/1000 mg, not 50 mg/500 mg. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada
Usual dose from the labelUS Janumet label: one tablet twice daily with meals. 50 mg/500 mg twice daily is the recommended starting dose for people not already taking metformin, with gradual dose escalation. Maximum 100 mg sitagliptin and 2000 mg metformin a day; two tablets of this strength reach the sitagliptin maximum
Half-lifeSitagliptin: apparent terminal half-life 12.4 hours after a single 100 mg dose; metformin: plasma elimination half-life about 6.2 hours (US label 12.3)
Packs30, 60 and 90 tablets (2, 4 and 6 Indian strips of 15); 15, 30 and 45 days at two tablets a day
Price per tablet$0.94 to $1.10 before shipping; about $1.89 to $2.20 a day at two tablets a day (our arithmetic)
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per tablet and per day

Prices below are as of October 2026; the pack selector shows the current price. Per-day figures are our arithmetic at the label schedule of one tablet twice a day.

PackPricePer tabletPer day (2 tablets)ShippingPer tablet with shippingPer day with shipping
30 tablets (15 days)$33$1.10$2.20$25$1.93$3.87
60 tablets (30 days)$60$1.00$2.00$25$1.42$2.83
90 tablets (45 days)$85$0.94$1.89$25$1.22$2.44

The larger packs cost less per tablet before shipping as well, and the $25 shipping charge is spread over more days. Every single pack is below the $149 free shipping line. Two 90 packs ($170, 180 tablets, 90 days) ship free and come to about $1.89 a day; a 90 plus a 60 pack ($145) is still below the line, so it pays $25 shipping and comes to about $2.27 a day (our arithmetic).

Do not overbuy a starting strength. The US label starts people new to metformin on this strength and raises the dose gradually, and the Janumet label does not set the steps or the timing: that is your doctor's decision. Many people will not stay on 50 mg/500 mg, and kidney function can change too, so buy only what your doctor expects you to need at this dose, and check the expiry dates on the strips.

How long a pack lasts. At one tablet twice a day, a 30 pack lasts 15 days, a 60 pack 30 days and a 90 pack 45 days. Delivery takes 7 to 14 business days, so order well before your current supply ends.

Compared with US Janumet and US generics

Janumet 50mg/500mg (ours, India)Janumet 50 mg/500 mg (US)US generic sitagliptin and metformin 50 mg/500 mgUS generic sitagliptin 100 mg once daily plus generic metformin 500 mg twice daily
Tablets a dayTwoTwoTwoThree
MakerMSD (India)Merck Sharp & DohmeSandoz or ApotexSeveral US generic makers
FDA approvedNoYesYesYes, each as a single-ingredient tablet
Cost per day$1.89 to $2.20 before shipping, $2.44 to $3.87 with shipping (our arithmetic)About $10.57 (NADAC $5.28345 a tablet)About $5.03 (NADAC $2.51460 a tablet)About $3.88 (NADAC $3.84929 plus 2 x $0.01483)

NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter, which adds a dispensing fee and margin, and insurance can change what you pay a great deal. The figures are per-tablet rows in the NADAC file dated 28 October 2026, all effective 21 October 2026: Janumet 50-500 mg ($5.28345), generic sitagliptin phosphate-metformin 50 mg-500 mg ($2.51460, Sandoz and Apotex NDCs), Zydus's Zituvimet 50-500 mg ($5.05824), generic sitagliptin phosphate 100 mg ($3.84929) and generic metformin HCl 500 mg ($0.01483).

Are US generics cheaper than ours? On these acquisition costs, not per tablet: the US generic combination tablet costs pharmacies $2.51, against our $0.94 to $1.10 before shipping ($1.22 to $1.93 with shipping on a single pack). Of the US options in the table above, the cheapest on NADAC is generic sitagliptin 100 mg once daily with generic metformin 500 mg twice daily, about $3.88 a day. Our 30 pack with shipping ($3.87 a day) costs about the same as that pharmacy acquisition cost, and our 60 and 90 packs with shipping ($2.83 and $2.44 a day) come in lower (our arithmetic). Counter prices for all of these US options are higher than NADAC, because NADAC leaves out the dispensing fee and margin, and in our view a generic copay will be the cheaper and simpler route for most insured US patients. If you are in the US with a prescription, ask your pharmacy for the generic price and your copay before you compare. FDA-approved generic sitagliptin and metformin tablets from Sandoz (ANDA 202388) and Apotex (ANDA 202426) list a US marketing start date of 28 May 2026, and the first NADAC rows for the generic 50 mg/500 mg tablet are effective 5 August 2026. Zydus also sells Zituvimet and an unbranded version under its own new drug application (NDA 216743, marketing start 14 March 2024), not as a generic of Janumet.

Sitagliptin 100 mg once a day plus metformin twice a day is a different schedule from Janumet twice a day. The US label says no efficacy studies were done with Janumet itself, and that bioequivalence of Janumet with sitagliptin and metformin tablets taken together was demonstrated. That work used US products; we have seen no bioequivalence study of the Indian pack against US Janumet. Any switch between products is a decision for your doctor, with closer glucose checks afterwards.

Which strength to choose

ProductSitagliptinMetforminHow it fits the labels
Janumet 50mg/500mg (this page)50 mg, twice daily500 mg immediate release, twice dailyUS Janumet label: the recommended starting dose for people not already taking metformin, with gradual dose escalation to reduce stomach side effects. Two tablets a day give the 100 mg sitagliptin maximum and 1000 mg metformin
Janumet 50mg/1000mg50 mg, twice daily1000 mg immediate release, twice dailyUS Janumet label: the recommended starting dose for people taking metformin 850 mg twice daily. Two tablets a day reach the maximum of 100 mg sitagliptin and 2000 mg metformin
Janumet XR CP100 mg, once daily (separate tablet)1000 mg sustained release, once daily (separate tablet)An Indian combipack with two separate tablets a day; once daily, with 1000 mg of metformin a day
Januvia 100mg100 mg, once dailyNoneSitagliptin alone, for example when metformin is not suitable
Januvia 50mg50 mg, once dailyNoneUS Januvia label: the sitagliptin dose at an eGFR of 30 to below 45
Januvia 25mg25 mg, once dailyNoneUS Januvia label: the sitagliptin dose at an eGFR below 30 or on dialysis (metformin is contraindicated there)

Never take more than two tablets a day. The US label sets the maximum at 100 mg sitagliptin and 2000 mg metformin a day, and the UK label says the dose should not exceed 100 mg sitagliptin a day. Two of these tablets already give 100 mg of sitagliptin, so a third or fourth tablet would take sitagliptin above both limits, even though the metformin would still be under 2000 mg (our arithmetic). If your doctor wants more metformin, the Janumet route is the 50mg/1000mg tablet, not extra 50mg/500mg tablets.

If you already take metformin. The US label says the starting dose in people already treated with metformin should give sitagliptin 50 mg twice daily "and the dose of metformin already being taken", and that people on metformin 850 mg twice daily start on 50 mg/1000 mg twice daily. So if you take metformin 500 mg twice a day now, this strength keeps your metformin the same and adds sitagliptin; if you take 850 mg or 1000 mg twice a day, this strength would cut your metformin, and the label points to the 50mg/1000mg tablet instead (our reading). Only your doctor can decide what to change.

The US label says not to split or divide Janumet tablets, and the UK label is written for people whose diabetes is not controlled on their maximal tolerated dose of metformin alone, or who already take sitagliptin and metformin; it gives no starting dose for people new to metformin. The UK has no Janumet 50 mg/500 mg on emc.

How to take Janumet 50mg/500mg

  1. Take it exactly as your doctor prescribes. The US label says to take it twice daily with meals, and the UK label says twice daily with meals "to reduce the gastrointestinal adverse reactions associated with metformin".
  2. Swallow the tablet whole. The US Medication Guide says "Do not break or cut JANUMET tablets before swallowing", and to tell your doctor if you cannot swallow them whole.
  3. If you miss a dose, the US Medication Guide says to take it as soon as you remember; if you do not remember until it is time for your next dose, skip the missed dose and go back to your regular schedule. "Do not take 2 doses of JANUMET at the same time."
  4. If your doctor raises your dose, follow the new instructions exactly and do not change strengths on your own. The US label recommends gradual dose escalation from this strength but does not give the steps.
  5. Have your kidney function (eGFR) tested before you start and at least once a year; older people need tests more often (US label 5.1, 5.4). The UK label suggests every 3 to 6 months for older people and those whose kidney function may worsen.
  6. Call your doctor for instructions if you become dehydrated (severe vomiting, diarrhoea or fever, or drinking much less than usual), plan surgery, or are going to have an X-ray or scan with injected dye (US Medication Guide).
  7. Check your blood sugar as your doctor tells you, and keep to your diet and exercise plan.
  8. Never start, stop, switch or combine diabetes medicines on your own.

The US label describes US Janumet 50 mg/500 mg as light pink tablets debossed "575". The Indian tablet may look different, so do not judge the Indian pack by the US description; read the carton and strip instead.

How well it works

The US label's main evidence for this combination is a 24 week factorial trial of 1,091 adults whose type 2 diabetes was not controlled by diet and exercise (A1C 7.5% to 11%). The trial gave sitagliptin and metformin as separate tablets; the label says none of its efficacy studies was done with Janumet itself, but that Janumet was bioequivalent to the two tablets taken together.

24 week armA1C changeDifference from placeboReached A1C below 7%Needed rescue treatment
Placebo+0.2n/a9%32%
Sitagliptin 100 mg once daily-0.7-0.820%21%
Metformin 500 mg twice daily-0.8-1.023%17%
Metformin 1000 mg twice daily-1.1-1.338%12%
Sitagliptin 50 mg with metformin 500 mg twice daily (the dose in two of these tablets)-1.4-1.643%8%
Sitagliptin 50 mg with metformin 1000 mg twice daily-1.9-2.166%2%

Source: US Janumet label section 14, Table 9 (mean baseline A1C 8.7% to 8.9%; rescue treatment was glyburide). In people who were not on any diabetes medicine when the trial started, the label gives an average A1C fall from baseline of 1.6% on sitagliptin 50 mg with metformin 500 mg twice daily, against 1.1% on metformin 500 mg twice daily alone. Average fasting glucose fell by 47 mg/dL on this combination, against a 6 mg/dL rise on placebo.

Bar chart of A1C reduction versus placebo at 24 weeks: sitagliptin 100 mg once daily 0.8 points, metformin 500 mg twice daily 1.0, metformin 1000 mg twice daily 1.3, sitagliptin 50 mg plus metformin 500 mg twice daily 1.6, sitagliptin 50 mg plus metformin 1000 mg twice daily 2.1.
Figure 1. A1C reduction beyond placebo for each drug alone and for the two combinations that match Janumet 50/500 and 50/1000 taken twice daily. Source: Janumet US prescribing information, Table 9.

Lower doses and extra care for some groups

  • Kidney impairment. The US Janumet label contraindicates it at an eGFR below 30 mL/min/1.73 m2 and says Janumet "is not recommended in patients with an eGFR between 30 and less than 45 mL/min/1.73 m2 because these patients require a lower dosage of sitagliptin than what is available in the fixed combination JANUMET product". The UK Janumet label (written for the 50 mg/1000 mg tablet, the only Janumet strength we found on the UK emc) sets these limits: at a GFR of 45 to 59 mL/min, metformin up to 2000 mg a day with a starting dose of "at most half of the maximum dose", and sitagliptin up to 100 mg; at 30 to 44 mL/min, metformin up to 1000 mg and sitagliptin up to 50 mg a day. It adds: "If no adequate strength of Janumet is available, individual monocomponents should be used instead of the fixed-dose combination." On our reading, two of these tablets a day (100 mg sitagliptin, 1000 mg metformin) fit the UK starting limits at 45 to 59, but give more sitagliptin than the UK limit at 30 to 44, so this strength is not suitable at an eGFR below 45 under either label. At that level the US Januvia label gives sitagliptin 50 mg once daily; any separate tablets are your doctor's decision.
  • Older people. The US label says dose selection for an elderly patient "should be cautious, usually starting at the low end of the dosing range", and that kidney function should be checked more often. The UK label says Janumet "should be used with caution as age increases".
  • Liver problems. The US label says Janumet "is not recommended in patients with hepatic impairment" (8.7) and to avoid it in people with clinical or laboratory evidence of liver disease (5.1). The UK label says it "must not be used in patients with hepatic impairment" and lists hepatic impairment as a contraindication.
  • People at risk of heart failure. See the heart failure section below.
  • People on a sulfonylurea or insulin. The US label says a lower dose of the sulfonylurea or insulin may be needed to reduce the risk of low blood sugar (5.6).
  • Children. The US label says safety and effectiveness have not been established in children. The UK label says it "should not be used in children and adolescents 10 to 17 years of age because of insufficient efficacy".

Lactic acidosis (boxed warning)

The US Janumet label carries a boxed warning for lactic acidosis caused by metformin, a rare build-up of acid in the blood. In the label's words: "Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain."

The boxed warning lists these risk factors: "renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment, and mitochondrial diseases." It ends: "If metformin-associated lactic acidosis is suspected, immediately discontinue JANUMET and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended." The UK label adds inadequately controlled diabetes, ketosis and prolonged fasting, and says that in case of dehydration (severe vomiting, diarrhoea, fever or reduced fluid intake), metformin "should be temporarily discontinued and contact with a health care professional is recommended".

Symptoms (US Medication Guide): feeling cold in your hands or feet, feeling dizzy or lightheaded, a slow or irregular heartbeat, feeling very weak or tired, unusual muscle pain, trouble breathing, feeling sleepy or drowsy, and stomach pains, nausea or vomiting. The Medication Guide says lactic acidosis "is a medical emergency and must be treated in the hospital", and to stop taking Janumet and call your doctor right away. The UK label says "the patient should stop taking metformin and seek immediate medical attention".

Contrast dye and surgery. The US label says to stop Janumet at the time of, or before, an iodinated contrast imaging procedure in people with an eGFR of 30 to 60, a history of liver disease, alcoholism or heart failure, or when contrast is given into an artery, then recheck eGFR 48 hours later and restart if kidney function is stable (2.3). It also says to stop it for a while when food and fluids are restricted for surgery or other procedures (5.1). The UK label says to stop it before or at the time of intravascular iodinated contrast (dye injected into a blood vessel) and not restart until at least 48 hours after, once kidney function has been rechecked and found stable, and to stop it at the time of surgery under general, spinal or epidural anaesthesia, restarting no earlier than 48 hours after surgery or after eating again, once kidney function has been rechecked and found stable.

Pancreatitis

The US label says there have been postmarketing reports of acute pancreatitis, "including fatal and non-fatal hemorrhagic or necrotizing pancreatitis", in patients taking Janumet, and that it is unknown whether people with a history of pancreatitis are at higher risk (5.2); Janumet has not been studied in them (1). In a pooled analysis of 19 trials (10,246 patients), acute pancreatitis occurred at 0.1 per 100 patient-years in both the sitagliptin and control groups (US 6.1).

Before you start, the US Medication Guide says to tell your doctor if you have ever had pancreatitis, gallstones, a history of alcoholism or high blood triglyceride levels. Stop taking it and call your doctor right away if you have pain in your stomach area "that is severe and will not go away", which may go through to your back, with or without vomiting. The UK label says that if acute pancreatitis is confirmed, Janumet "should not be restarted", and that caution should be used in people with a history of pancreatitis.

Heart failure

The US label says an association between DPP-4 inhibitor treatment and heart failure "has been observed in cardiovascular outcomes trials for two other members of the DPP-4 inhibitor class" (5.3). It tells doctors to consider the risks and benefits before starting Janumet in people at risk of heart failure, "such as those with a prior history of heart failure and a history of renal impairment", and to watch them for heart failure during treatment.

For sitagliptin itself, the UK Janumet label reports the TECOS trial: 14,671 people with type 2 diabetes and established cardiovascular disease took sitagliptin or placebo on top of usual care for a median of 3 years.

TECOS outcomeSitagliptin (7,332)Placebo (7,339)Hazard ratio (95% CI)
Cardiovascular death, heart attack, stroke or hospital stay for unstable angina839 (11.4%)851 (11.6%)0.98 (0.89 to 1.08)
Hospital admission for heart failure228 (3.1%)229 (3.1%)1.00 (0.83 to 1.20)
Death from any cause547 (7.5%)537 (7.3%)1.01 (0.90 to 1.14)

Selected rows. Source: UK Janumet SmPC section 5.1, Table 3 (intention-to-treat population). The label says sitagliptin "did not increase the risk of major adverse cardiovascular events or the risk of hospitalisation for heart failure" compared with usual care without it. Metformin is a separate issue: the UK Janumet label lists cardiac or respiratory failure, recent heart attack and shock, as diseases that may cause tissue hypoxia, among its contraindications, and the US label lists acute congestive heart failure as a lactic acidosis risk.

Signs of heart failure (US Medication Guide): increasing shortness of breath or trouble breathing, especially when you lie down; swelling or fluid retention, especially in the feet, ankles or legs; an unusually fast increase in weight; and unusual tiredness. Contact your doctor right away if you notice them.

Low blood sugar (hypoglycaemia)

In the factorial trial, low blood sugar was reported by 1.6% of people on sitagliptin with metformin, against 0.8% on metformin alone and 0.6% on placebo (US label 6.1). It became more common when the combination was used with a sulfonylurea or insulin: when sitagliptin was added to metformin and glimepiride for 24 weeks, 16.4% reported low blood sugar, against 0.9% on placebo; added to metformin and insulin, 15.3% against 8.2% (US label 6.1, Table 3). The UK label gives 13.8% with a sulphonylurea and 10.9% with insulin (4.8).

Signs (US Medication Guide): headache, drowsiness, irritability, hunger, dizziness, confusion, sweating, feeling jittery, weakness and a fast heartbeat. If you take a sulfonylurea or insulin, ask your doctor whether that dose should be lowered, and how to treat a low reading. If someone is unconscious or cannot swallow, call emergency services; as general first aid, do not put food or drink in their mouth.

Side effects

In the 24 week placebo-controlled factorial trial of sitagliptin given with immediate-release metformin, in people whose diabetes was not controlled by diet and exercise:

EffectSitagliptin with metforminMetformin aloneSitagliptin alonePlacebo
Diarrhoea7.5%7.7%2.8%4.0%
Upper respiratory tract infection6.2%5.2%4.5%5.1%
Headache5.9%3.8%1.1%2.8%
Nausea4.8%5.5%1.1%1.1%
Vomiting2.2%0.5%0%0.6%
Abdominal pain3.0%3.8%3.4%2.3%

Source: US Janumet label section 6.1, Table 1 (events in 5% or more on the combination and more than on placebo) and Table 2 (pre-selected stomach events). The label pools the metformin 500 mg and 1000 mg twice daily arms, so it gives no separate rates for the 50 mg/500 mg dose. It says the stomach side effects of the combination were similar to those of metformin alone. Metformin's common start-of-treatment effects are diarrhoea, nausea and vomiting, flatulence, abdominal discomfort, indigestion, weakness and headache (US 6.1). Taking the tablets with meals lowers the chance of an upset stomach (US Medication Guide).

Vitamin B12. In 29 week metformin trials, vitamin B12 fell to below normal in about 7% of patients. The US label advises checking blood counts every year and vitamin B12 every 2 to 3 years (5.5). The UK label says the risk rises with dose and duration, and to check B12 if anaemia or neuropathy suggests a deficiency.

Other warnings in the US label: serious allergic reactions (anaphylaxis, angioedema and skin reactions including Stevens-Johnson syndrome), which began within the first 3 months, some after the first dose (5.7); severe and disabling joint pain, which can start from one day to years after starting (5.8); bullous pemphigoid, a blistering skin condition that has needed hospital treatment (5.9); and worsening kidney function, including acute kidney failure, sometimes needing dialysis (5.4). Postmarketing reports, without a reliable frequency, also include liver enzyme rises, liver injury, tubulointerstitial nephritis, constipation, vomiting, headache, muscle, limb and back pain, itching, mouth ulcers and rhabdomyolysis (6.2). The UK label lists low platelets (thrombocytopenia) as rare and interstitial lung disease with frequency not known (4.8).

When to get urgent help

Get emergency help, or ask someone to call for you, if you have:

  • Signs of lactic acidosis: feeling very weak or tired, unusual muscle pain, trouble breathing, feeling cold in your hands or feet, dizziness, a slow or irregular heartbeat, or stomach pain with nausea or vomiting. Stop the tablets and get medical help straight away.
  • Severe stomach pain that will not go away, which may go through to your back, with or without vomiting: possible pancreatitis. Stop the tablets and call your doctor right away.
  • Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, hives, a rash, or blistering or peeling skin. The US Medication Guide says to stop the tablets and call your doctor right away or get emergency medical help.
  • Low blood sugar that does not improve after taking sugar, comes back, or causes confusion, fits, fainting or loss of consciousness.
  • Sudden or worsening breathlessness, especially lying down, or fast swelling of the legs or weight gain: possible heart failure.
  • Taking more than your prescribed dose, or a child swallowing the tablets. The US Medication Guide says to call your doctor or local Poison Control Center right away. Poison lines (our addition, not from the label): US 1-800-222-1222, Australia 13 11 26. The US label says lactic acidosis was reported in about 32% of metformin overdose cases.

Tell the emergency staff that you take sitagliptin and metformin (Janumet 50mg/500mg), how much and when.

Blisters or skin erosions (US label 5.9) and severe joint pain (5.8) also need prompt medical advice, and so, in our view, does unusual bruising or bleeding (the UK label lists low platelets as a rare effect).

Who should not take Janumet 50mg/500mg

Never take it if (US Janumet label contraindications, unless the UK label is named):

  • your eGFR is below 30 mL/min/1.73 m2 (severe kidney impairment)
  • you have acute or chronic metabolic acidosis, including diabetic ketoacidosis
  • you have had a serious allergic reaction to Janumet, sitagliptin or metformin, such as anaphylaxis or angioedema. The UK label covers allergy to the active substances or any of the excipients.
  • UK Janumet label contraindications: diabetic pre-coma; acute conditions with the potential to alter kidney function (dehydration, severe infection, shock, intravascular iodinated contrast); acute or chronic disease which may cause tissue hypoxia, such as cardiac or respiratory failure, recent heart attack or shock; hepatic impairment; acute alcohol intoxication or alcoholism; and breastfeeding

Should not use, not recommended or use only with care:

  • Type 1 diabetes: the US label says Janumet "should not be used" in type 1 diabetes, and the UK label says it should not be used in type 1 diabetes and "must not be used for the treatment of diabetic ketoacidosis".
  • eGFR 30 to below 45: "not recommended" (US label).
  • Liver impairment: "not recommended" (US label); a contraindication in the UK label.
  • Known mitochondrial disease such as MELAS or MIDD: "not recommended" (US and UK labels).
  • A history of pancreatitis: the US label says Janumet has not been studied in these patients; the UK label says use caution.
  • A history of angioedema with another DPP-4 inhibitor: the US label says use caution (5.7).
  • People at risk of heart failure: weigh the risks and benefits first (US 5.3).
  • Alcohol: the US label warns against excessive alcohol intake (5.1), and its interaction table says to "Warn patients against alcohol intake while receiving JANUMET" (7). The UK label lists alcohol under concomitant use not recommended.

Pregnancy and breastfeeding. The UK Janumet label says it "should not be used during pregnancy", and that if a patient wishes to become pregnant or a pregnancy occurs, treatment should be discontinued and the patient switched to insulin as soon as possible; it lists breastfeeding as a contraindication. The US label says the limited data in pregnant women are not enough to inform a drug-associated risk, that poorly controlled diabetes in pregnancy carries risks for mother and baby, and that for breastfeeding the benefits should be weighed against the mother's need for the medicine and possible effects on the infant. The US label also says metformin may cause ovulation in some women who do not ovulate, which can lead to an unplanned pregnancy. Talk to your doctor before a pregnancy.

Medicines that interact

  • Sulfonylureas and insulin: more low blood sugar; a lower dose of the sulfonylurea or insulin may be needed (US 5.6, 7).
  • Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide): may raise the lactic acidosis risk; the US label says to consider more frequent monitoring.
  • Medicines that reduce metformin clearance, such as ranolazine, vandetanib, dolutegravir and cimetidine: can raise metformin levels; the US label says to consider the benefits and risks of using them together.
  • Medicines that can raise blood sugar (US label): thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, oestrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isoniazid. Watch for loss of control when one is started and for low blood sugar when one is stopped. The UK label adds beta-2 agonists.
  • Medicines that can affect the kidneys, such as NSAIDs (including COX-2 inhibitors), ACE inhibitors, angiotensin II receptor blockers and diuretics, especially loop diuretics: the UK Janumet label says close monitoring of kidney function is needed.
  • Digoxin: the UK label says sitagliptin raised digoxin exposure (AUC) by about 11% on average, that no digoxin dose change is recommended, and that people at risk of digoxin toxicity should be monitored.
  • Alcohol: it strengthens metformin's effect on lactate (US label Table 4).

Tell your doctor or pharmacist about every medicine and supplement you take before you start, and before you start anything new.

Prescription and legal status

In India, Truemeds and Medkart mark Janumet 50/500 as prescription required, and the carton in our product photo carries "Rx". India's regulator (DCG(I)) approved sitagliptin 50 mg with metformin 500 mg or 1000 mg film-coated tablets on 28 April 2008.

In the US, Janumet (NDA 022044, approved 30 March 2007) and generic sitagliptin and metformin tablets are prescription medicines, and the FDA says personal importation of unapproved medicines is illegal in most circumstances. In the UK, Janumet 50 mg/1000 mg is a prescription only medicine (emc); we found no 50 mg/500 mg sitagliptin and metformin tablet on emc, which is not the full MHRA register. In Canada, Janumet 50/500 (DIN 02333856) is a marketed prescription medicine, and generic 50/500 tablets from Apotex and Sandoz are marketed (Health Canada Drug Product Database). In Australia, sitagliptin with metformin 50 mg/500 mg is on the PBS (item 9449H, 56 tablets, streamlined authority required) as Janumet and several generics; the dispensed price for the maximum quantity is A$35.56 and a general patient pays A$25.00 (PBS schedule, checked 30 October 2026). This Indian Janumet pack is not registered with the FDA, the MHRA, the TGA or Health Canada. Check the rules where you live.

Buying genuine Janumet 50mg/500mg

The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and it advises UK buyers to "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers this Indian pack, which is not authorised in the UK. When your order arrives, read the strip: it should say Janumet, list sitagliptin 50 mg and metformin hydrochloride 500 mg, name the maker, and carry a batch number and an expiry date. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. Check your blood glucose closely during the first weeks on any new supply, and tell your doctor if your readings change. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Janumet 50mg/500mg to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Shipping costs a flat $25 on orders under $149 and is free from $149. The Truemeds listing says to store it below 30°C and PharmEasy says not above 30°C in a cool and dry place; the UK Janumet label says do not store above 25°C, and the US label says room temperature, 20°C to 25°C. Keep the tablets in the strip until you take them. Diabetes tablets should not run out: order well before your current supply ends, and do not stop or ration your tablets while you wait. See our shipping page and refund policy.

Related guides

Sources

  • Janumet (sitagliptin and metformin HCl) tablets, US prescribing information and Medication Guide, Merck Sharp & Dohme LLC, revised 8/2026 (DailyMed setid d19c7ed0-ad5c-426e-b2df-722508f97d67, SPL version 61, published 27 August 2026; still current on 30 October 2026): boxed warning, sections 1, 2.1 to 2.3, 3, 4, 5.1 to 5.9, 6.1 (Tables 1 to 3), 6.2, 7 (Table 4), 8.1 to 8.7, 10, 12.3, 14 (Table 9), 16, 17. DailyMed
  • Januvia (sitagliptin) tablets, US prescribing information, Merck Sharp & Dohme LLC (DailyMed setid f85a48d0-0407-4c50-b0fa-7673a160bf01): section 2.2 (kidney dosing). DailyMed
  • Janumet 50 mg/1000 mg film-coated tablets, UK SmPC, Merck Sharp & Dohme (UK) Limited, PLGB 53095/0036, revised 14 June 2025: sections 4.1 to 4.6, 4.8, 4.9, 5.1 (TECOS, Table 3), 6.4. emc
  • US Food and Drug Administration, NDC directory and Drugs@FDA via openFDA: sitagliptin and metformin hydrochloride tablets 50 mg/500 mg, Sandoz (NDC 0781-5801, ANDA 202388) and Apotex (NDC 60505-3658, ANDA 202426), marketing start date 28 May 2026; Zydus Zituvimet and unbranded sitagliptin and metformin (NDA 216743), marketing start date 14 March 2024; checked 30 October 2026.
  • Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026, file dated 28 October 2026, per-NDC rows effective 21 October 2026: Janumet 50-500 mg $5.28345; sitagliptin phosphate-metformin 50 mg-500 mg $2.51460 (first rows effective 5 August 2026); Zituvimet 50-500 mg $5.05824; sitagliptin phosphate 100 mg $3.84929; metformin HCl 500 mg $0.01483. data.medicaid.gov
  • Health Canada Drug Product Database: Janumet 50/500 (DIN 02333856), marketed, prescription; Apo-Sitagliptin-Metformin 50/500 (DIN 02435772) and Sandoz Sitagliptin-Metformin 50/500 (DIN 02503956), marketed; checked 30 October 2026. Health Canada
  • Pharmaceutical Benefits Scheme, item 9449H, sitagliptin 50 mg with metformin hydrochloride 500 mg tablet, 56; checked 30 October 2026. PBS
  • Electronic Medicines Compendium (UK) search for sitagliptin and metformin: Janumet 50 mg/1000 mg; generics 50 mg/850 mg and 50 mg/1000 mg; no 50 mg/500 mg product listed.
  • Central Drugs Standard Control Organisation. Fixed dose combinations approved by DCG(I) since 1961 to 31 December 2019, item 818 (28.04.08).
  • Indian pharmacy listings for Janumet 50/500, checked 30 October 2026: Truemeds (MSD Pharmaceuticals Private Ltd, strip of 15, prescription required, store below 30°C), Medkart (MSD Pharmaceuticals Private Limited, 15 tablets, prescription required, room temperature) and PharmEasy (15 tablets in a strip, store not above 30°C, "Made by" Abbott Healthcare).
  • Medicines and Healthcare products Regulatory Agency, press release on buying medicines online, 13 February 2026.
  • US Food and Drug Administration. Personal importation policy.

Frequently asked questions

What is Janumet 50mg/500mg?

Janumet 50mg/500mg is a film-coated tablet for adults with type 2 diabetes that contains two medicines: sitagliptin 50 mg, a DPP-4 inhibitor (the medicine in Januvia), and metformin hydrochloride 500 mg. We sell the Indian Janumet from MSD Pharmaceuticals Pvt Ltd, sold in India in strips of 15 tablets. It is taken with diet and exercise and is not for type 1 diabetes.

Is Indian Janumet 50/500 the same as US Janumet?

It has the same two medicines at the same strengths as US Janumet 50 mg/500 mg, but it is the Indian pack marketed by MSD Pharmaceuticals in India, which is not registered with the FDA, MHRA, TGA or Health Canada, and we have seen no bioequivalence study comparing it with the US tablet. The US tablet is described as light pink; the Indian one may look different. If you switch between products, check your blood glucose more closely and tell your doctor.

How much does Janumet 50mg/500mg cost per tablet and per day?

As of October 2026, our packs cost $33 for 30 tablets ($1.10 a tablet), $60 for 60 ($1.00) and $85 for 90 ($0.94), before shipping. At two tablets a day that is about $1.89 to $2.20 a day. Shipping is $25 under $149 and free from $149, which brings the cost to about $2.44 to $3.87 a day for a single pack (our arithmetic). The pack selector shows the current price.

Is generic Janumet 50/500 cheaper in the US?

Generic sitagliptin and metformin 50 mg/500 mg tablets from Sandoz and Apotex list a US marketing start date of 28 May 2026 (FDA NDC directory). In the NADAC file dated 28 October 2026, US pharmacies paid $2.51460 per generic 50 mg/500 mg tablet and $5.28345 per Janumet tablet. That acquisition cost is higher than our price per tablet, but it is not what you pay at the counter. If you are in the US with a prescription and insurance, ask your pharmacy for the generic price and your copay first: for many people it will be the cheaper and simpler route.

How do I take Janumet 50mg/500mg?

The US and UK labels say to take Janumet twice daily with meals, which lowers the chance of an upset stomach. Swallow the tablet whole; the US Medication Guide says not to break or cut it. If you miss a dose, take it as soon as you remember, but if you do not remember until it is time for your next dose, skip the missed one and go back to your regular schedule. Never take two doses at the same time.

Is 50mg/500mg the right strength for me?

That is your doctor's decision. The US label names 50 mg/500 mg twice daily as the starting dose for people not already taking metformin, with gradual dose escalation to reduce stomach side effects. If you already take metformin 500 mg twice a day, this strength keeps that dose and adds sitagliptin. If you take metformin 850 mg or 1000 mg twice a day, this strength would lower your metformin; the label starts those people on 50 mg/1000 mg. See our Janumet 50mg/1000mg page for the higher strength.

What is the maximum dose, and can I take more tablets to raise my dose?

The US label sets the maximum at 100 mg sitagliptin and 2000 mg metformin a day. Two Janumet 50mg/500mg tablets a day already give 100 mg of sitagliptin, so never take more than two tablets in a day, even though the metformin is only 1000 mg. If your doctor wants more metformin, the Janumet option is the 50mg/1000mg tablet, not extra 50mg/500mg tablets.

How long does a pack last?

At one tablet twice a day, a 30 pack lasts 15 days, a 60 pack 30 days and a 90 pack 45 days. Because this is a starting strength and your doctor may raise the dose, buy only what you expect to need at this dose. Delivery takes 7 to 14 business days, so order well before your current supply ends, and do not stop or ration your tablets while you wait.

Can I take Janumet 50mg/500mg if I have kidney problems?

Have your kidney function (eGFR) checked before you start and at least once a year. The US label contraindicates Janumet at an eGFR below 30 and says it is not recommended at 30 to below 45, because people in that range need less sitagliptin than the fixed combination gives. The UK label limits sitagliptin to 50 mg a day at a GFR of 30 to 44, which two of these tablets exceed. At 45 to 59, two tablets a day fit the UK starting limit for metformin (our reading).

What are the side effects and warnings?

In the label's main trial, diarrhoea (7.5%), upper respiratory infection (6.2%), headache (5.9%) and nausea (4.8%) were common on the combination (500 mg and 1000 mg metformin arms pooled). Janumet has a boxed warning for lactic acidosis, a rare but serious build-up of acid in the blood caused by metformin. Other label warnings include pancreatitis, heart failure, kidney problems, low vitamin B12, low blood sugar with a sulfonylurea or insulin, serious allergic reactions, severe joint pain and bullous pemphigoid. Stop the tablets and get medical help straight away for signs of lactic acidosis or severe stomach pain that will not go away.

Do I need a prescription for Janumet, and how long does delivery take?

Janumet is a prescription medicine in the US, the UK, Canada and Australia, and Indian listings mark it prescription required. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances, and the MHRA advises UK buyers to use only UK-registered pharmacies. You need a doctor for kidney and glucose monitoring in any case. We ship to the US, UK, Australia and Canada in 7 to 14 business days, with tracking; shipping is $25 under $149 and free from $149.

Medical References

  1. 1.ClinicalTrials.gov NCT02456428

Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA

Guide to Type 2 DiabetesAn evidence-based guide to type 2 diabetes medicines: how metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors and combination tablets differ on dosing, side effects and cost.

Related articles

Customer Reviews

No reviews yet. Bought Janumet 50mg/500mg? Tell other buyers how it went.